ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Family Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

9,853Medicare Part D Prescriptions Filled, Including Refills

Rank: 169 out of 2680

$652K Total Retail Price of All Prescriptions

Rank: 181 out of 2680

365 Patients Receiving at Least One Drug in Part D
94%Patients 65 Years and Older
82% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in New York
Lower avg

Schedule Two
Controlled Substances

15% of this provider’s 365 patients filled at least one prescription for a schedule two drug, compared to an average of 4%.

Schedule Three
Controlled Substances

8% of this provider’s 365 patients filled at least one prescription for a schedule three drug, compared to an average of 6%.

Risky Drugs to Seniors

1% of this provider’s 9,231 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

23% of this provider’s prescriptions were for brand-name drugs, compared to an average of 27%.

Prescription Price

$66 was the average price of a prescription from this provider, compared to $67 among peers.

Prescriptions per Patient

27 is the average number of prescriptions (including refills) per patient, compared to an average of 18.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in New York
LEVOTHYROXINE SODIUM 428 417 1 4
FUROSEMIDE 419 396 2 7
JANTOVEN 393 393 3 81
DONEPEZIL HCL 364 364 4 28
CITALOPRAM HBR 339 339 5 22
WARFARIN SODIUM 307 226 6 12
LISINOPRIL 300 299 7 5
OMEPRAZOLE 285 274 8 2
MIRTAZAPINE 280 280 9 48
SIMVASTATIN 228 228 10 1
METOPROLOL TARTRATE 216 210 11 8
AMLODIPINE BESYLATE 176 168 12 3
SERTRALINE HCL 176 176 12 23
NAMENDA 159 159 14 43
PREDNISONE 139 135 15 45
QUETIAPINE FUMARATE 136 136 16 72
RISPERIDONE 134 120 17 67
CYMBALTA 133 121 18 56
METOPROLOL SUCCINATE 131 131 19 11
CARBIDOPA-LEVODOPA 99 99 20 88
TAMIFLU 98 96 21 136
ISOSORBIDE MONONITRATE ER 91 91 22 57
SPIRONOLACTONE 85 85 23 86
NYSTOP 80 76 24 183
GABAPENTIN 78 56 25 21
POTASSIUM CHLORIDE 72 70 26 29
LIDODERM 71 69 27 74
DIVALPROEX SODIUM 71 63 27 90
GLIPIZIDE 70 70 29 71
ATENOLOL 70 70 29 14
POLYETHYLENE GLYCOL 3350 70 65 29 55
EXELON 69 69 32 162
CIPROFLOXACIN HCL 69 66 32 85
TAMSULOSIN HCL 66 66 34 25
ALLOPURINOL 65 65 35 42
SEROQUEL 63 63 36 161
ALBUTEROL SULFATE 62 61 37 97
KLOR-CON M20 59 47 38 101
IPRATROPIUM-ALBUTEROL 58 58 39 110
BACLOFEN 56 0 40 123
TRAMADOL HCL 55 54 41 33
LEVETIRACETAM 55 21 41 94
METFORMIN HCL 52 48 43 6
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on Nov. 13, 2013.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.